Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 34 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
331 20.9 months NHL 5 Chemotherapy
Santobono-Pausilipon Hospital Italy 8/2014
Treatment Details: Patients: This study involved 30 children with central nervous system (CNS) relapsed/refractory acute leukemia/lymphoma. The median patient age was 9.4 years and 21 were male. Treatment
 
332 20.8 months Malignant pleural mesothelioma 5 Radiation
Zurich University Hospital Switzerland 1/2014
Treatment Details: Patients: This study involved malignant pleural mesothelioma patients who had received prior chemotherapy and surgery and were divided into two separate treatment groups. Group A consisted
 
333 20.8 months GBM 4 Chemotherapy
Fondazione IRCCS Istituto Neurologico Italy 6/2007
Treatment Details: Patients: This phase II trial involved 54 patients with glioblastoma multiforme. The patients ranged in age from 26 to 68 years old, with a median age of 53.5 years. The majority (75.9%) o
 
334 20.7 months Advanced malignant pleural mesothelioma 4 Chemotherapy
Instituto Nacional de Cancerología Mexico 5/2014
Treatment Details: Patients: This phase 2 study involved 41 advanced malignant pleural mesothelioma patients. The average patient age was 59.7 years and 65.9% were male. Treatment: Patients received chem
 
335 20.6 months Metastatic, castration-resistant prostate cancer 4 Biologic therapy
Chemotherapy
Hormone
University Hospital of Cologne Germany 10/2012
Treatment Details: Patients: This phase 2 study involved metastatic castration-resistant prostate cancer who had not received prior chemotherapy. Patients were divided into two separate treatment groups. Gr
 
336 20.6 months Advanced NSCLC 4 Chemotherapy
Radiation
Sahlgrenska University Hospital Sweden 7/2009
Treatment Details: Patients: This phase 2 study involved 151 people with locally advanced non-small cell lung cancer. There were 78 men and 73 women. The median age was 62, ranging from 43 to 78 years. T
 
337 20.6 months Metastatic breast cancer 4 Chemotherapy
European Organization for the Research and Treatment of Cancer Data Center Belgium 7/2002
Treatment Details: Patients: This Phase II study involved 271 treated patients with metastatic breast cancer. Patients were divided into two groups – Group AT was comprised of 136 patients; Group AC was compr
 
338 20.6 months Advanced NSCLC 4 Chemotherapy
Radiation
Vanderbilt University Medical Center United States 9/2005
Treatment Details: Patients: This Phase II study involved 51 patients with locally advanced (stage IIIA or IIIB) non–small-cell lung cancer. Thirty-four patients were men, and seventeen were women. The mean
 
339 20.5 months metastatic breast cancer 4 Chemotherapy
Kumamoto City Hospital Japan 5/2005
Treatment Details: Patients: This phase II study involved 35 patients with metastatic breast cancer. The median age of the women was 56 years, and 26 had been previously treated for recurrent or metastatic di
 
340 20.5 months Metastatic breast cancer 5 Chemotherapy
European Organization for the Research and Treatment of Cancer Data Center Belgium 6/2002
Treatment Details: Patients: This Phase II study involved 271 treated patients with metastatic breast cancer. Patients were divided into two groups – Group AT was comprised of 136 patients; Group AC was compr
 
Page 34 of 187  | Previous Page  | Next Page